Skip to main content

Better red than dead, wine drinkers outlive teetotalers

Wine drinkers outlive nondrinkers, or so the studies show. But nondrinkers are not all created equal, and that along with other factors makes it difficult to draw firm inferences about healthy drinking. For example, an oft-cited problem is what is called the “sick quitter” hypothesis, which holds that among the nondrinkers are those with a history of problem drinking. Their health having already suffered, the comparison may be unfair by lumping them in with healthier folks who abstain for religious or other personal reasons. Moderate wine drinkers may differ socioeconomically or in other important demographic variables. Anti-alcohol advocates are quick to point out such problems with population studies.


So while there are several studies showing greater average lifespan in wine drinkers, more needs to be done. One good study out this summer may give comfort to wine drinkers and help dispel some of the critics. The project, a joint effort of Stanford University and the University of Texas, looked at all-cause mortality over a 20-year period, comparing various factors to death rates, beginning with a study cohort of individuals aged 55-65. As we have come to expect from such studies, death rate was twice as high in nondrinkers compared to moderate drinkers, and 70% higher in heavy drinkers. This is the classic J-shaped curve that defines just about any disease condition when plotted against wine consumption.

What’s different about this latest report is that the researchers went to great lengths to adjust for the effects of previous problem drinkers and socioeconomic factors. Taking all of this into account, the differences were less dramatic but still clear, with moderate drinkers still only about half as likely to die of any cause compared to teetotalers.

Ultimately the question of how drinking affects lifespan is too complicated to reduce to a simple mathematical formula anyway. Alcohol remains a part of whatever the formula is, just in the right amounts. Wine drinkers do a lot of other healthy things, and have a higher quality of life in old age too. Viva vino!

Holahan CJ, Schutte KK, Brennan PL, Holahan CK, Moos BS, Moos RH. Late-Life Alcohol Consumption and 20-Year Mortality. Alcohol Clin Exp Res. 2010 Aug 24.

Comments

Popular posts from this blog

Versatile resveratrol: the ultimate skin care ingredient?

  Part 1 Recently I was honored to join Professors David Sinclair of Harvard and Joseph Vercauteren of the University of Montpelleir at an anti-aging symposium at the invitation of Mathilde Thomas of Caudalie in Paris. Caudalie has been using wine extracts (and specifically resveratrol) in their products for more than 15 years, after Vercauteren identified it in wine grape vines. Sinclair has become well known for his work identifying the role of sirtuin (SIRT) genes in anti-aging, and resveratrol as a natural sirtuin activator. While much remains to be proven, it is fair to say that science is finally beginning to have an impact on skin care. With an increasing understanding of what causes aging in skin cells and how botanical antioxidants such as resveratrol work at a molecular level, there is no excuse to use anti-aging skin care products that don’t multitask. Before delving into the potential benefits of resveratrol in skin care, it may help to review ho...

Revisiting resveratrol: new findings rekindle anti-aging debate

Just when we thought the bloom was off the rosé for resveratrol, the anti-oxidant polyphenol from red wine with multiple anti-aging properties, along comes new research giving life to the debate. But first a bit of background: As I detailed in my book Age Gets Better with Wine , it is well-documented that wine drinkers live longer and have lower rates of many diseases of aging. Much or the credit for this has been given to resveratrol, though there isn’t nearly enough of it in wine to explain the effects. Nevertheless, I dubbed it the “miracle molecule” and when it was reported to activate a unique life-extension phenomenon via a genetic trigger called SIRT, an industry was born, led by Sirtris Pharmaceuticals, quickly acquired by pharma giant Glaxo. The hope was that resveratrol science could lead to compounds enabling people to live up to 150 years and with a good quality of life. But alas, researchers from other labs could not duplicate the results, and clinical studies disa...